Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 582

1.

Prognostic implications of serum microRNA-21 in colorectal cancer.

Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.

J Surg Oncol. 2013 Nov;108(6):369-73. doi: 10.1002/jso.23415. Epub 2013 Aug 23.

PMID:
23970420
2.

Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.

Zhou T, Zhang GJ, Zhou H, Xiao HX, Li Y.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):229-33. doi: 10.1097/MEG.0000000000000002.

PMID:
24150523
3.

miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.

Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, Liu W, Qin H.

Gut. 2012 Oct;61(10):1447-53. doi: 10.1136/gutjnl-2011-301122. Epub 2011 Nov 3.

PMID:
22052060
4.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
5.

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.

Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

Ann Surg. 2014 Apr;259(4):735-43. doi: 10.1097/SLA.0b013e3182a6909d.

6.

High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.

Zheng J, Dong P, Gao S, Wang N, Yu F.

Hepatogastroenterology. 2013 May;60(123):549-52.

PMID:
23108086
7.

Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Zhang P, Ji DB, Han HB, Shi YF, Du CZ, Gu J.

World J Gastroenterol. 2014 Sep 14;20(34):12241-8. doi: 10.3748/wjg.v20.i34.12241.

8.

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.

Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH.

Lancet Oncol. 2013 Dec;14(13):1295-306. doi: 10.1016/S1470-2045(13)70491-1. Epub 2013 Nov 13. Erratum in: Lancet Oncol. 2014 Jan;15(1):e4.

PMID:
24239208
9.

Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.

Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH.

J Clin Gastroenterol. 2009 Oct;43(9):831-7. doi: 10.1097/MCG.0b013e31819cc731.

PMID:
19461527
10.

Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.

Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX.

World J Gastroenterol. 2014 Aug 28;20(32):11340-6. doi: 10.3748/wjg.v20.i32.11340.

11.

Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients.

Kaduthanam S, Gade S, Meister M, Brase JC, Johannes M, Dienemann H, Warth A, Schnabel PA, Herth FJ, Sültmann H, Muley T, Kuner R.

Lung Cancer. 2013 May;80(2):223-7. doi: 10.1016/j.lungcan.2013.01.013. Epub 2013 Feb 11.

PMID:
23410826
12.

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

J Natl Cancer Inst. 2013 Jun 19;105(12):849-59. doi: 10.1093/jnci/djt101. Epub 2013 May 23.

13.

Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.

Tanaka K, Miyata H, Yamasaki M, Sugimura K, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S607-15. doi: 10.1245/s10434-013-3093-4. Epub 2013 Jul 10.

PMID:
23838916
14.

The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.

Wu P, Tang RN, Zou JH, Wang FC.

Hepatogastroenterology. 2012 Oct;59(119):2164-7. doi: 10.5754/hge12539.

PMID:
23178553
15.

Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.

Yang J, Liu H, Wang H, Sun Y.

Pathol Res Pract. 2013 Aug;209(8):490-4. doi: 10.1016/j.prp.2013.04.018. Epub 2013 Jun 6.

PMID:
23827213
16.

Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.

Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA, Lam AK.

Mol Carcinog. 2014 Feb;53 Suppl 1:E36-44. doi: 10.1002/mc.21993. Epub 2013 Sep 5.

PMID:
24009195
17.

Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.

Lin Q, Chen T, Lin Q, Lin G, Lin J, Chen G, Guo L.

J Surg Oncol. 2013 Jun;107(7):767-71. doi: 10.1002/jso.23312. Epub 2013 Apr 23.

PMID:
23609137
18.

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.

19.

Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study.

Zhu W, Liu X, He J, Chen D, Hunag Y, Zhang YK.

BMC Cancer. 2011 Sep 15;11:393. doi: 10.1186/1471-2407-11-393.

20.

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.

Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, Wang J.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):953-7. doi: 10.1097/MEG.0b013e32835ed691.

PMID:
23751352

Supplemental Content

Support Center